Catalyst
Slingshot members are tracking this event:
Teva (TEVA) Launches Generic Version of Merck's CUBICIN for Complicated Skin and Bloodstream Infections in U.S
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 15, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Cubicin, Antibacterial Injection, Complicated Skin And Skin Structure Infection, Gram-positive Bacteria, Staphylococcus Aureus, Daptomycin
